Navigation Links
InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
Date:11/5/2009

marks of Roche.

Financial tables follow

                                InterMune, Inc.
          PRELIMINARY CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
              (unaudited, in thousands, except per share amounts)

                                  Three Months Ended   Nine Months Ended
                                      September 30        September 30
                                      ------------        ------------
                                     2009      2008*     2009      2008*
                                     ----      ----      ----      ----
      Revenue, net
        Actimmune                  $6,493    $7,505   $19,635   $23,297
        Collaboration revenue      20,818    15,818    22,454    17,454
                                   ------    ------    ------    ------
          Total revenue, net       27,311    23,323    42,089    40,751

      Costs and expenses:
        Cost of goods sold          1,019     1,413     5,737     7,276
        Research and
         development               20,608    25,618    67,965    78,028
        General and
         administrative             9,916     8,205    26,911    22,744
        Acquired research and
        development milestones      1,750         -    15,250         -
        Restructuring charges          55         -       795         -
                                       --        --       ---        --
          Total costs and
           expenses                33,348    35,236   116,658   108,048

      Loss from operations         (6,037)  (11,913)  (74,569)  (67,297)

      Interest income                 331     1,212     1,498     4,644
      Interest expense             (2,714)   (2,971)   (7,934)  (10,067)
      Loss on extinguishment
       of debt                       (724)        -   (10,264)   (1,294)
      Other income (expense)          396        18     6,043     1,286
                                      ---        --     -----    
'/>"/>
SOURCE InterMune, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
2. InterMune Announces Start of Phase 1b Trial of ITMN-191
3. InterMune Announces Top-Line Results of Phase 1b Trial of ITMN-191 (R7227) and Provides Program Update
4. InterMune Provides Additional Information on ITMN-191 (R7227) MAD Study Results
5. InterMune Announces Progress on Pirfenidone in IPF
6. InterMune Announces Receipt of Fast Track Designation for Pirfenidone From FDA
7. InterMune Announces Start of 14-Day Triple Combination Study of ITMN-191 in Patients With Chronic Hepatitis C
8. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
9. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
10. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
11. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... MADRID , June 2, 2015 ... annuale della American Society of Clinical Oncology    ... di fase 3 SAR3007, resi noti dal dipartimento Ricerca ... evidenziato un significativo miglioramento della sopravvivenza libera da progressione ... rispetto al trattamento con dacarbazina in pazienti con liposarcoma ...
(Date:6/1/2015)... , June 1, 2015  LaunchPad Medical, ... a definitive agreement to license Stryker Corporation,s (NYSE: ... based on a unique synthetic biomaterial.  Under the ... exclusive worldwide license from Stryker for this technology ... pending U.S. patents and includes data from multiple ...
(Date:6/1/2015)... , June 1, 2015  Research Solutions, Inc. (OTCQB: ... and medical (STM) information for life science companies, academic ... to present at the LD Micro Invitational being held ... in Los Angeles . ... on Wednesday, June 3rd at 9:30 a.m. Pacific time, ...
Breaking Medicine Technology:PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 2PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 3PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 4PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 5PharmaMar annuncia che lo studio di Janssen ha evidenziato che la trabectedina migliora il controllo della malattia in pazienti con sarcoma dei tessuti molli in stato avanzato 6LaunchPad Medical Executes Definitive License Agreement with Stryker for Novel Bone Adhesive Technology 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 2Research Solutions to Present at the LD Micro Invitational on June 3, 2015 3
... LLC has launched a full line of non-prescription, topical ... relief of nerve pain caused by diabetes, post-shingles, chemotherapy, ... the only full line of skin care and pain ... developed from the ground up in oils, lotions and ...
... cites in its newly published " Medical Imaging ... medical imaging equipment exceeded $21 billion in ... Medical imaging can ... computed tomography (CT), positron emission tomography (PET), single ...
Cached Medicine Technology:Affordable Nerve Pain Treatment Now Available in the U.S. 2Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010 2Global Spending on Medical Imaging Equipment Exceeded $21 Billion in 2010 3
(Date:6/2/2015)... TheCelebrityDresses.com, a popular online store selling ... their summer fashion cocktail dresses. The company carries more ... would be suitable for a wide variety of summer ... designs and make high quality trendy special occasion ... high quality satin, chiffon and cotton. Their products feature ...
(Date:6/2/2015)... 2015 First Choice Emergency Room ... in the United States, named Kenneth Alan Totz, D.O.as ... Road facility. , “We are pleased to announce ... facility,” said Dr. James M. Muzzarelli, Executive Medical Director ... received his undergraduate degree from St. Edwards University in ...
(Date:6/2/2015)... Thermi, formerly ThermiAesthetics, a fast ... transitioned into its new company headquarters in Irving, ... continued rapid worldwide expansion and houses the corporate ... Thermi employees, including those of the warehousing, shipping ... one of the fastest growing aesthetic companies in ...
(Date:6/2/2015)... Join us for a new event in Westwood, ... Rhonda Martin , who overcame her brain aneurysm during the ... to raising awareness and funds for brain aneurysm research. ... that there will be one less case of someone suffering ... to join the 1st Anniversary Awareness Walk in Honor ...
(Date:6/1/2015)... City, NY (PRWEB) June 02, 2015 ... honors Miriam Wirski as a 2015-2016 inductee ... is recognized with this prestigious distinction for leadership in ... for professional women, boasting more than 700,000 members and ... present Miriam with this prestigious honor,” said NAPW President ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Kenneth Alan Totz as New Medical Director of Houston – Jones Road Facility 2Health News:Thermi Moves to New Corporate Headquarters as Rapid Company Expansion Continues 2Health News:New Awareness Raising Event in Westwood, NJ to Benefit Renowned Brain Aneurysm Foundation 2Health News:National Association of Professional Women Inducts Miriam Wirski, Holistic Life Coach, Into its VIP Woman of the Year Circle 2
... a region of a human chromosome that is associated ... People with EoE frequently have difficulty eating or may ... further suggests that a suspected so-called master allergy gene ... rare but debilitating disorder. EoE is characterized ...
... between stress and death risk, researchers say , SUNDAY, March ... misery and death has helped researchers identify a gene variant ... U.S. research team focused on a gene called IL6, which ... to cardiovascular disease, neurodegeneration and some types of cancer. , ...
... ... , ... 2010 -- On Saturday, March 6 Yvonne’s Day Spa opened at Market Square at Potomac ... known in the Middle East and Asia as “doctor fish”, are minnow-like and toothless, and ...
... ... ... ... ...
... Louis, MO - Breast cancer patients with early stage disease ... benefit from radiation after mastectomy, because of the low present-day ... finding that could one day change the course of treatment ... at The University of Texas M. D. Anderson Cancer. ...
... ... Abelson says proposed curbs address an illusion instead of the real problem — doctors ... ... injury lawyer in Maryland and Washington, DC, says proposed limits on damage awards in ...
Cached Medicine News:Health News:NIAID media availability: Food allergy-related disorder linked to master allergy gene 2Health News:Gene Variant May Help Some Overcome Adversity 2Health News:Nibble Fish Arrive in Arlington Just in Time for Beautiful Toes for Oscar Night 2Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 2Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 3Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 4Health News:The Pentagon Tragedy: Mental Illness, Violence and What Reporters Should Ask 5Health News:Most early-stage breast cancer patients may not need radiation after mastectomy 2Health News:Most early-stage breast cancer patients may not need radiation after mastectomy 3Health News:Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says 2Health News:Congressional Concession On Medical Malpractice Awards Will Not Lower Health Care Costs And Will Hurt Patients' Rights, Washington, DC Attorney Says 3
...
...
...
Open blade speculum designed for both temporal and superior approach ocular surgery. Thumb screw adjusting mechanism. Manufactured in titanium....
Medicine Products: